Nucleus Commercial Finance launches the first Post-CBILS product to support SMES

Nucleus Commercial Finance launches the first Post-CBILS product to support SMES

Nucleus Commercial Finance launches the first Post-CBILS product to support SMES.png
 
 

Nucleus Commercial Finance, one of the UK’s leading fintech lenders, has today announced the launch of Business Growth Loans. This is the first product of its kind designed to support SMEs as a top-up to the government’s Coronavirus Business Interruption Loan Scheme (CBILS), as well as helping businesses nationwide with additional funding once the scheme ends. 

Business Growth Loans are powered by Nucleus’ award-winning technology, enabling SMEs to apply, get decisions and receive funding within hours. This technology is leading the way in the industry, with automated decisions using machine learning and AI, allowing businesses to receive the money they need quickly.

With SMEs expected to face a significant funding gap once CBILS finishes on 31 March, Business Growth Loans provide SMEs with immediate and flexible financial support to operate in the ongoing challenging environment. Limits start from £3,000 up to a maximum of £25,000, with a term of six months. Qualifying businesses will have the option to apply for a top-up every quarter.

Brokers and introducers will be able to submit Business Growth Loans applications to the industry-leading myNucleus portal. Businesses can also directly apply via Nucleus’ website.

Chirag Shah, CEO, Nucleus Commercial Finance comments: “We continue to be fully supportive of CBILS and are proud to have lent a total of £180m to date through the scheme. Our lending through CBILS means we can see the additional support businesses currently require and the funding gap it will leave once the scheme ends. This has driven us to design a product that will continue to provide businesses with the vital finance they need to survive and recover.”

The launch of Business Growth Loans follows Nucleus securing a new £200m funding line in January from two global investment management firms. The finance increases Nucleus’ capacity to support businesses in 2021 through this new product and a number of existing solutions.

Shah added: “The ability for SMEs to apply, get a decision and receive funding on the same day demonstrates the power of technology in the lending process. Investment in innovation from fintechs means we are best positioned in the industry to support SMEs post-CBILS thanks to the ability to design flexible products. These creative solutions, which are driven by cutting-edge technology, will further reinforce that fintechs can no longer be considered an alternative; we are the true mainstream lender.”


APPII joins forces with UK health-tech giants to launch UK’s first end-to-end, digitally verified COVID-19 test

APPII joins forces with UK health-tech giants to launch UK’s first end-to-end, digitally verified COVID-19 test

Finalists for the 2021 Bold Woman Award by Veuve Clicquot announced

Finalists for the 2021 Bold Woman Award by Veuve Clicquot announced